Geode Capital Management LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 19,956,219 shares of the healthcare conglomerate's stock after acquiring an additional 319,515 shares during the period. UnitedHealth Group accounts for 0.8% of Geode Capital Management LLC's holdings, making the stock its 14th biggest position. Geode Capital Management LLC owned about 2.17% of UnitedHealth Group worth $10,068,869,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. Howard Capital Management Group LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth $341,000. Principal Financial Group Inc. lifted its position in shares of UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after purchasing an additional 180,479 shares in the last quarter. Bamco Inc. NY grew its holdings in shares of UnitedHealth Group by 2.0% in the third quarter. Bamco Inc. NY now owns 56,890 shares of the healthcare conglomerate's stock valued at $33,262,000 after acquiring an additional 1,089 shares in the last quarter. Atom Investors LP grew its stake in UnitedHealth Group by 5,098.1% in the 3rd quarter. Atom Investors LP now owns 21,676 shares of the healthcare conglomerate's stock valued at $12,674,000 after purchasing an additional 21,259 shares during the period. Finally, Benjamin Edwards Inc. increased its holdings in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock worth $26,060,000 after buying an additional 41,308 shares during the last quarter. Institutional investors own 87.86% of the company's stock.
Analyst Upgrades and Downgrades
UNH has been the topic of a number of research reports. KeyCorp restated an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price for the company in a research report on Friday, January 10th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $629.32.
Check Out Our Latest Report on UnitedHealth Group
UnitedHealth Group Trading Up 0.1 %
NYSE:UNH traded up $0.49 on Wednesday, hitting $523.61. The stock had a trading volume of 2,368,702 shares, compared to its average volume of 4,265,457. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $478.95 billion, a price-to-earnings ratio of 33.78, a PEG ratio of 1.37 and a beta of 0.62. The company has a fifty day moving average price of $509.06 and a two-hundred day moving average price of $542.96.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the firm earned $5.83 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 54.19%.
Insider Buying and Selling
In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.33% of the company's stock.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
